3D Cell Culture Global Market

3D Cell Culture Global Market - Forecast to 2024

Publishing Date :	February, 2018
Report Code :	HCBT0106
Price:	Single license $4,950 Site license $6,750 Global license $9,000

Note: The report would be dispatched after confirmation of payment

3D cell culture is the method of creating an artificial environment that allows the cells to grow and interact within 3D structures. According to IQ4I analysis, the 3D cell culture global market is expected to grow at double digit CAGR to reach $1,485.1 million by 2024. Substantial R&D investments, use of 3D cell culture models in drug discovery and research as alternative to animal testing, emergence of microfluidic technology and bioprinting and increasing focus on regenerative medicine are some of the driving factors for this industry. However, lack of experienced and skilled professionals, budget restrictions for small and medium sized laboratories, lack of consistency in 3D cell culture products, stringent process controls for handling capabilities and ethical concerns over the use of animal sources are hindering the market to grow.

3D cell culture global market is classified based on technology, products, application, end-users, and geography. Based on technology the 3D cell culture market can be divided into two segments i.e., Scaffold based approaches and Scaffold free approaches. The scaffold based approaches are further classified into scaffolds, hydrogels and others. The scaffold free approaches are classified as the hang drop method, forced floating, agitation based methods, and microfludics. Based on products the segment is further classified as cells and tissues, media, sera and reagents, microplates and others, assay kits, scaffolds, and others (bioreactors and incubators). The application segment can be classified as basic research, toxicity and drug screening, tissue engineering, stem cell research, drug discovery, gene therapy and cancer research. The end-users segment can be classified as academic institutes, biotechnology and pharmaceutical industries and others.

Based on geography 3D cell culture global market is classified as North America, Europe, APAC and Rest of the world. North America accounts for the highest market share of 46.2% followed by Europe. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for 3D cell culture products.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
• North America
o U.S.
o Others

• Europe
o Germany
o U.K.
o France
o Others

• Asia-Pacific
o China
o Japan
o Korea
o Others

• Rest of the World (RoW)
o Brazil
o Rest of Latin America
o Middle-East and Others

1 EXECUTIVE SUMMARY
2 INTRODUCTION

2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY

2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET

3.3.1 DRIVERS AND OPPORTUNITIES

3.3.1.1 SUBSTANTIAL R&D INVESTMENTS FOR 3D CELL CULTURE
3.3.1.2 USE OF 3D CELL CULTURE MODELS IN DRUG DISCOVERY AND RESEARCH AS AN ALTERNATIVE TO ANIMAL TESTING
3.3.1.3 EMERGENCE OF MICROFLUIDIC TECHNOLOGY AND BIOPRINTING
3.3.1.4 INCREASING FOCUS ON REGENERATIVE MEDICINE

3.3.2 RESTRAINTS AND THREATS

3.3.2.1 LACK OF EXPERIENCED AND SKILLED PROFESSIONALS
3.3.2.2 BUDGET RESTRICTION FOR SMALL AND MEDIUM SIZED LABORATORIES AND LACK OF CONSISTENCY IN 3D CELL CULTURE PRODUCTS
3.3.2.3 STRINGENT PROCESS CONTROLS FOR ADVANCED HANDLING CAPABILITIES
3.3.2.4 ETHICAL CONCERN OVER USE OF ANIMAL SOURCES

3.4 REGULATORY AFFAIRS

3.4.1 UNITED STATES
3.4.2 EUROPE
3.4.3 INDIA
3.4.4 JAPAN

3.5 TECHNOLOGICAL ADVANCEMENTS

3.5.1 INTRODUCTION
3.5.2 ORGAN-ON-CHIP
3.5.3 3D BIOPRINTING
3.5.4 SINGLE USE REACTORS

3.6 PORTER’S FIVE FORCE ANALYSIS

3.6.1 THREAT OF NEW ENTRANTS
3.6.2 THREAT OF SUBSTITUTES
3.6.3 BARGAINING POWER OF SUPPLIERS
3.6.4 BARGAINING POWER OF BUYERS
3.6.5 RIVALRY AMONG EXISTING COMPETITORS

3.7 SUPPLY CHAIN ANALYSIS

3.7.1 RAW MATERIAL SUPPLIER:
3.7.2 PRODUCT MANUFACTURERS:-
3.7.3 3D CELL CULTURE PRODUCTS DISTRIBUTORS
3.7.4 END-USERS

3.8 MARKET SHARE ANALYSIS BY MAJOR PLAYERS

4 3D CELL CULTURE GLOBAL MARKET, BY TECHNOLOGY

4.1 INTRODUCTION
4.2 SCAFFOLD BASED PLATFORMS

4.2.1 SCAFFOLDS
4.2.2 HYDROGELS
4.2.3 OTHERS

4.3 SCAFFOLD FREE PLATFORMS

4.3.1 HANG DROP METHOD
4.3.2 FORCED FLOATING
4.3.3 AGITATION BASED METHODS
4.3.4 MICROFLUIDICS

5 3D CELL CULTURE GLOBAL MARKET, BY PRODUCTS

5.1 INTRODUCTION
5.2 CELLS AND TISSUES
5.3 MEDIA, SERA AND REAGENTS
5.4 MICROPLATES AND OTHERS
5.5 ASSAY KITS
5.6 SCAFFOLDS

5.6.1 NATURAL SCAFFOLDS
5.6.2 SYNTHETIC SCAFFOLDS
5.6.3 HYBRID COMPOSITE
5.6.4 HYDROGELS

5.7 OTHERS

6 3D CELL CULTURE GLOBAL MARKET, BY APPLICATION

6.1 INTRODUCTION
6.2 BASIC RESEARCH
6.3 TOXICITY AND DRUG SAFETY SCREENING
6.4 TISSUE ENGINEERING
6.5 STEM CELL RESEARCH
6.6 DRUG DISCOVERY
6.7 CANCER RESEARCH
6.8 GENE THERAPY

7 3D CELL CULTURE GLOBAL MARKET, BY END-USERS

7.1 INTRODUCTION
7.2 ACADEMIC INSTITUTES
7.3 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES
7.4 OTHERS

8 REGIONAL ANALYSIS

8.1 INTRODUCTION
8.2 NORTH AMERICA

8.2.1 U.S.
8.2.2 OTHERS

8.3 EUROPE

8.3.1 GERMANY
8.3.2 U.K.
8.3.3 FRANCE
8.3.4 OTHERS

8.4 ASIA-PACIFIC

8.4.1 CHINA
8.4.2 JAPAN
8.4.3 KOREA
8.4.4 OTHERS

8.5 REST OF THE WORLD

8.5.1 BRAZIL
8.5.2 REST OF LATIN AMERICA
8.5.3 MIDDLE EAST AND OTHERS

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 COLLABORATIONS & PARTNERSHIPS
9.3 NEW PRODUCT LAUNCHES
9.4 AGREEMENTS, EXPANTIONS & MERGERS
9.5 COMPANY MATRIX

10 MAJOR COMPANIES

10.1 BECTON DICKINSON AND COMPANY

10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS

10.2 CORNING INCORPORATED

10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS

10.3 INSPHERO AG

10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS

10.4 JSR CORPORATION (ORGANOGENIX INC.)

10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS

10.5 KURARAY CO. LTD

10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS

10.6 LONZA GROUP

10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 SERVICE PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS

10.7 MERCK KGAA

10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS

10.8 NANO 3D BIOSCIENCES, INC

10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS

10.9 ORGANOVO HOLDINGS INC.

10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS

10.10 THERMO FISHER SCIENTIFIC, INC

10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS

LIST OF TABLES

TABLE 1 3D CELL CULTURE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
TABLE 2 3D CELL CULTURE GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2016-2024) ($MN)
TABLE 3 SCAFFOLD BASED PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
TABLE 4 SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 5 SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 6 HYDROGELS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 7 OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 8 SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
TABLE 9 SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 10 HANGDROP METHOD MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 11 FORCED FLOATING MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 12 AGITATION BASED METHODS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 13 MICROFLUIDICS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 14 3D CELL CULTURE GLOBAL MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
TABLE 15 CELLS & TISSUES MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 16 MEDIA, SERA & REAGENTS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 17 MICROPLATES & OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 18 ASSAY KITS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 19 SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 20 SCAFFOLDS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
TABLE 21 NATURAL SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 22 SYNTHETIC SCAFFOLDS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 23 HYBRID COMPOSITE MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 24 HYDROGELS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 25 OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 26 3D CELL CULTURE GLOBAL MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
TABLE 27 BASIC REASEARCH MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 28 TOXICITY AND DRUG SAFETY SCREENING MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 29 TISSUE ENGINEERING MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 30 STEM CELL RESEARCH MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 31 DRUG DISCOVERY MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 32 CANCER RESEARCH MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 33 GENE THERAPY MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 34 3D CELL CULTURE GLOBAL MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
TABLE 35 ACADEMIC INSTITUTES MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 36 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 37 OTHERS MARKET REVENUE, BY REGIONS, (2016-2024) ($MN)
TABLE 38 3D CELL CULTURE GLOBAL MARKET REVENUE, BY REGION, (2016-2024) ($MN)
TABLE 39 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
TABLE 40 NORTH AMERICA SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 41 NORTH AMERICA SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 42 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
TABLE 43 NORTH AMERICA SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
TABLE 44 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
TABLE 45 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
TABLE 46 EUROPE 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
TABLE 47 EUROPE SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 48 EUROPE SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 49 EUROPE 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
TABLE 50 EUROPE SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
TABLE 51 EUROPE 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
TABLE 52 EUROPE 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
TABLE 53 APAC 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
TABLE 54 APAC SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 55 APAC SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 56 APAC 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
TABLE 57 APAC SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
TABLE 58 APAC 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
TABLE 59 APAC 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
TABLE 60 ROW 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2016-2024) ($MN)
TABLE 61 ROW SCAFFOLD BASED PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 62 ROW SCAFFOLD FREE PLATFORMS MARKET REVENUE, BY TYPE (2016-2024) ($MN)
TABLE 63 ROW 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS, (2016-2024) ($MN)
TABLE 64 ROW SCAFFOLDS MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
TABLE 65 ROW 3D CELL CULTURE MARKET REVENUE, BY APPLICATION, (2016-2024) ($MN)
TABLE 66 ROW 3D CELL CULTURE MARKET REVENUE, BY END-USERS, (2016-2024) ($MN)
TABLE 67 COLLABORATIONS & PARTNERSHIPS (JAN 2016 – JAN 2018)
TABLE 68 NEW PRODUCT LAUNCH(JAN 2016 – JAN 2018)
TABLE 69 AGREEMENTS, EXPANTIONS & MERGERS (JAN 2016 – JAN 2018)
TABLE 70 COMPANY MATRIX: COMPANY V/S PRODUCT OFFERING
TABLE 71 BECTON DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
TABLE 72 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
TABLE 73 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
TABLE 74 BECTON DICKINSON AND COMPANY: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
TABLE 75 CORNING INCORPORATED: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
TABLE 76 CORNING INCORPORATED: TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
TABLE 77 CORNING INCORPORATED: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
TABLE 78 KURARAY CO. LTD: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
TABLE 79 KURARAY CO. LTD. : TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
TABLE 80 KURARAY CO. LTD: TOTAL REVENUE, BY GEOGRAPHY (2012-2014) ($MN)
TABLE 81 LONZA GROUP: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
TABLE 82 LONZA GROUP: TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
TABLE 83 LONZA GROUP: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)
TABLE 84 MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
TABLE 85 MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
TABLE 86 MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
TABLE 87 ORGANOVO HOLDINGS INC.: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
TABLE 88 THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE AND R&D EXPENSES (2015-2017) ($MN)
TABLE 89 THERMO FISHER SCIENTIFIC, INC : TOTAL REVENUE, BY SEGMENT, (2015-2017) ($MN)
TABLE 90 THERMO FISHER SCIENTIFIC, INC: TOTAL REVENUE, BY GEOGRAPHY (2015-2017) ($MN)

LIST OF FIGURES

FIGURE 1 GLOBAL 3D CELL CULTURE MARKET SHARE AND REVENUE, BY REGION, (2016-2024) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: 3D CELL CULTURE GLOBAL MARKET
FIGURE 3 3D CELL CULTURE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 3D CELL CULTURE GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 3D CELL CULTURE: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 3D CELL CULTURE GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 8 3D CELL CULTURE MARKET: PORTER’S ANALYSIS
FIGURE 9 3D CELL CULTURE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 10 3D CELL CULTURE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017
FIGURE 11 3D CELL CULTURE GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2017-2024) ($MN)
FIGURE 12 3D CELL CULTURE SCAFFOLD BASED PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2017) ($MN)
FIGURE 13 3D CELL CULTURE SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2017) ($MN)
FIGURE 14 SCAFFOLD BASED PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
FIGURE 15 SCAFFOLD FREE PLATFORMS GLOBAL MARKET REVENUE, BY TYPE, (2016-2024) ($MN)
FIGURE 16 3D CELL CULTURE GLOBAL MARKET REVENUE, BY PRODUCT, (2017 V/S 2024) ($MN)
FIGURE 17 SCAFFOLDS GLOBAL MARKET REVENUE, BY TYPE, (2017 V/S 2024) ($MN)
FIGURE 18 3D CELL CULTURE GLOBAL MARKET REVENUE, BY APPLICATION, (2017 V/S 2024) ($MN)
FIGURE 19 3D CELL CULTURE GLOBAL MARKET SHARE, BY APPLICATION, (2017) (%) CAGR (%)
FIGURE 20 3D CELL CULTURE GLOBAL MARKET REVENUE, BY END-USERS, (2017 V/S 2024) ($MN)
FIGURE 21 3D CELL CULTURE GLOBAL MARKET REVENUE, BY REGION (2016-2024) ($MN)
FIGURE 22 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
FIGURE 23 NORTH AMERICA SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
FIGURE 24 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 25 NORTH AMERICA SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
FIGURE 26 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
FIGURE 27 NORTH AMERICA 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
FIGURE 28 U.S. 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 29 U.S. 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 30 OTHER NORTH AMERICAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 31 OTHER NORTH AMERICAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 32 EUROPE 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
FIGURE 33 EUROPE SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
FIGURE 34 EUROPE 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 35 EUROPE SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
FIGURE 36 EUROPE 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
FIGURE 37 EUROPE 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
FIGURE 38 GERMANY 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 39 GERMANY 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 40 U.K. 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 41 U.K. 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 42 FRANCE 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 43 FRANCE 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 44 OTHER EUROPEAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 45 OTHER EUROPEAN COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 46 APAC 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
FIGURE 47 APAC SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
FIGURE 48 APAC 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 49 APAC SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
FIGURE 50 APAC 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
FIGURE 51 APAC 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
FIGURE 52 CHINA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 53 CHINA 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 54 JAPAN 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 55 JAPAN 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 56 KOREA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 57 KOREA 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 58 OTHER APAC COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 59 OTHER APAC COUNTRIES 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 60 ROW 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY (2017 VS 2024) ($MN)
FIGURE 61 ROW SCAFFOLD BASED PLATFORMS & SCAFFOLD FREE PLATFORM MARKET, BY TYPE (2017 VS 2024) ($MN)
FIGURE 62 ROW 3D CELL CULTURE MARKET REVENUE, BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 63 ROW SCAFFOLDS MARKET REVENUE, BY TYPE (2017 VS 2024) ($MN)
FIGURE 64 ROW 3D CELL CULTURE MARKET REVENUE, BY APPLICATION (2017 VS 2024) ($MN)
FIGURE 65 ROW 3D CELL CULTURE MARKET REVENUE, BY END-USERS (2017 VS 2024) ($MN)
FIGURE 66 BRAZIL 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 67 BRAZIL 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 68 REST OF LATIN AMERICA 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 69 REST OF LATIN AMERICA 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 70 MIDDLE EAST AND OTHERS 3D CELL CULTURE MARKET REVENUE, BY TECHNOLOGY, BY END-USERS & BY PRODUCTS (2017 VS 2024) ($MN)
FIGURE 71 MIDDLE EAST AND OTHERS 3D CELL CULTURE MARKET REVENUE, BY APPLICATIONS (2017 VS 2024) ($MN)
FIGURE 72 KEY GROWTH STRATEGIES, (JAN 2016 – JAN 2018)
FIGURE 73 OVERVIEW: BECTON DICKINSON AND COMPANY
FIGURE 74 SWOT: BECTON DICKINSON AND COMPANY
FIGURE 75 OVERVIEW: CORNING INCORPORATED
FIGURE 76 SWOT: CORNING INCORPORATED
FIGURE 77 SWOT: INSPHERO AG
FIGURE 78 SWOT: ORGANOGENIX INC.
FIGURE 79 OVERVIEW: KURARAY CO. LTD
FIGURE 80 SWOT: KURARAY CO. LTD
FIGURE 81 OVERVIEW: LONZA GROUP
FIGURE 82 SWOT: LONZA GROUP
FIGURE 83 OVERVIEW: MERCK KGAA
FIGURE 84 SWOT: MERCK KGAA
FIGURE 85 SWOT: NANO 3D BIOSCIENCES
FIGURE 86 OVERVIEW: ORGANOVO HOLDINGS INC.
FIGURE 87 SWOT: ORGANOVO HOLDINGS INC
FIGURE 88 OVERVIEW: THERMO FISHER SCIENTIFIC INC
FIGURE 89 SWOT: THERMO FISHER SCIENTIFIC, INC

LIST OF COMPANIES MENTIONED IN THE REPORT

1 300 MICRONS GMBH
2 3D BIOTEK, LLC
3 3D MATRIX CO.
4 3DTRO AB
5 ADVANCED BIOMATRIX, INC.
6 AIM BIOTECH PTE LTD.
7 AKRON BIOTECHNOLOGY, LLC
8 AMSBIO LLC
9 ASCENDANCE
10 ASPECT BIOSYSTEMS
11 ASTERAND BIOSCIENCE
12 AVANTICELL SCIENCE
13 BASF
14 BECTON, DICKINSON AND COMPANY
15 BELLBROOKS LABS
16 BELLCO GLASS, INC
17 BIOCELLCHALLENGE
18 BIOGELX LTD.
19 BIOLAMINA AB
20 BIOMERIX
21 BIOVISION, INC.
22 BIOZOL GMBH
23 BISS TGT
24 BRTI LIFE SCIENCES
25 CELARTIA
26 CELL APPLICATIONS, INC.
27 CELL BIO LABS
28 CELL SPRING
29 CELLECBIOTEK AG
30 CELLENDES GMBH
31 CELLEVATE AB
32 CELLINK
33 CELLNTEC ADVANCED CELL SYSTEMS AG
34 CELPROGEN
35 CELVIVO IVS
36 CHARLES RIVER LABORATORIES
37 CNBIO INNOVATIONS LTD.
38 CORNING INC.
39 CTIBIOTECH
40 CYFUSE BIOMEDICAL KK
41 CYTOO
42 DIA GENODE
43 DWK LIFE SCIENCES
44 EBERS MEDICAL TECHNOLOGY SL
45 ECTICA TECHNOLOGIES AG
46 ELECTROSPINNING COMPANY
47 EMULATE, INC.
48 ESI BIO
49 FIBERCELL SYSTEMS INC.
50 FLUIDINOVA SA
51 FUJIFILM
52 GENLANTIS (GENE THERAPY SYSTEMS, INC.)
53 GLOBAL CELL SOLUTIONS, INC
54 GRADIENTECH AB
55 GREINER BIO-ONE GMBH
56 GUANGZHOU JET BIO-FILTRATION CO., LTD.
57 KERANETICS
58 HOKKAIDO SODA
59 HUREL CORP
60 IBIDI GMBH
61 INSPHERO
62 INVIVO SCIENCES
63 IRVINE SCIENTIFIC
64 IV TECH SRL
65 JAPAN VILENE COMPANY
66 JSR CORPORATION (ORGANOGENIX INC.)
67 KIRKSTALL LTD
68 KOKEN CO. LTD.
69 KOLLOIDIS BIOSCIENCES
70 KURARAY CO., LTD.
71 LENA BIOSCIENCES, INC.
72 LIFECORE BIOMEDICAL,
73 LOCATE THERAPEUTICS
74 LONZA GROUP
75 MATRICEL GMBH
76 MATTEK CORPORATION
77 MENICON LIFE SCIENCE
78 MERCK KGAA
79 MICROTISSUES, INC.
80 MILTENYI BIOTEC GMBH
81 MIMETAS B.V.
82 MIRUS BIO
83 NANO 3D BIOSCIENCES INC
84 NANOFIBER SOLUTIONS
85 NANOLIVE SA
86 NANOPHARMA A.S.
87 NEUROMICS INC
88 ORGANOVO HOLDINGS, INC
89 PEPGEL LLC
90 PERKINELMER
91 PISHON BIOMEDICAL
92 PRODIZEN
93 PROMEGA CORPORATION
94 PROMOCELL GMBH
95 PROTISTA INTERNATIONAL AB
96 QGEL BIO
97 QUORUS BIOTECH (PTY) LTD.
98 REALBIO TECHNOLOGY INC.
99 REGENOVO
100 REPROCELL (REINNERVATE LTD. )
101 SANGI CO., LTD.
102 SARTORIUS STEDIM BIOTECH
103 STEMCELL TECHNOLOGIES INC.
104 STEMTEK
105 SUMITOMO BAKELITE CO. LTD.
106 SYNTHECON, INC
107 SYNVIVO LLC
108 TAKARA BIO INC (CLONTECH)
109 TETEC AG (B BRAUN)
110 THE WELL BIOSCIENCE INC.
111 THERMO FISHER SCIENTIFIC
112 TREVIGEN, INC.
113 UPM
114 VORNIA BIOMATERIALS LTD.
115 XANOFI
116 ZPREDICTA, INC.

3D Cell Culture Global Market - Forecast to 2024

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS

about IQ4I

Get in Touch

IQ4I recent reports

Orthopaedic Devices Global Market – Forecast To 2027

Cell Analysis Global Market - Forecast to 2027

Ventilators global Market – Forecast To 2027

Artificial intelligence in Healthcare Global Market – Forecast To 2027

Genomics Global Market – Forecast To 2027

Neurovascular Intervention Devices Global Market – Forecast To 2027

Subscribe to Newsletter

Biotechnology

3D Cell Culture Global Market - Forecast to 2024

3D Cell Culture Global Market - Forecast to 2024

LIST OF TABLES

LIST OF FIGURES

LIST OF COMPANIES MENTIONED IN THE REPORT

IQ4I HEALTHCARE REPORTS

Orthopaedic Devices Global Market – Forecast To 2027

Cell Analysis Global Market - Forecast to 2027

Ventilators global Market – Forecast To 2027

Artificial intelligence in Healthcare Global Market – Forecast To 2027

Genomics Global Market – Forecast To 2027

Neurovascular Intervention Devices Global Market – Forecast To 2027